Although the MAP3K15 gene has not been reported to be associated with neurodegenerative disorders, it has recently been described in a large-scale type 2 diabetes analysis based on a cohort of 454,787 participants from the UK22. This evidence concerns the gene MAP3K15 and type 2 diabetes mellitus.